| Wed, Feb 3, 2010 |
| |
Coverage initiated on Onyx Pharma by Brean Murray Briefing.com (Wed, Feb 3)
|
| Tue, Feb 2, 2010 |
| |
Onyx Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference PRNewswire (Tue, Feb 2)
|
| |
Onyx and FDA agree on cancer drug study design AP (Tue, Feb 2)
|
| |
UPDATE - Onyx says FDA agrees on blood cancer drug trial design at Reuters (Tue, Feb 2)
|
| |
Onyx Pharmaceuticals Announces Agreement with the FDA on a Special Protocol Assessment for Planned Phase 3 Carfilzomib Combination Trial in Relapsed M PRNewswire (Tue, Feb 2)
|
| Mon, Feb 1, 2010 |
| |
Onyx Pharmaceuticals Appoints Ted W. Love, M.D., as Head of Research & Development PRNewswire (Mon, Feb 1)
|
| Fri, Jan 29, 2010 |
| |
Wake Up! You Still Have to Pay Attention at Motley Fool (Fri, Jan 29)
|
| |
5-Star Stocks Poised to Pop: Res-Care at Motley Fool (Fri, Jan 29)
|
| Wed, Jan 27, 2010 |
| |
67% Decline In Consumable Cost For Human Genome Sequencing Seen In 2010 By First Analysis Equity Valuation Expert Wall Street Transcript (Wed, Jan 27)
|
| Fri, Jan 22, 2010 |
| |
Pfizer's Great Data Won't Do Much at Motley Fool (Fri, Jan 22)
|
| Tue, Jan 19, 2010 |
| |
Digging Deeper Into Adventrx Pharmaceuticals at TheStreet.com (Tue, Jan 19)
|
| Fri, Jan 15, 2010 |
| |
3 Reasons to Sell Sequenom Today at Motley Fool (Fri, Jan 15)
|
| Wed, Jan 13, 2010 |
| |
3 Stocks Springing Back at Motley Fool (Wed, Jan 13)
|
| Mon, Jan 11, 2010 |
| |
More Biotech Nuggets From the J.P. Morgan Confab: BioBuzz at TheStreet.com (Mon, Jan 11)
|
| Tue, Jan 5, 2010 |
| |
Onyx Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference PRNewswire (Tue, Jan 5)
|
| |
Analysts Name Top Biotech Stocks for 2010: BioBuzz at TheStreet.com (Tue, Jan 5)
|
| Wed, Dec 30, 2009 |
| |
Pfizer Pflubs -- You Expected Otherwise? at Motley Fool (Wed, Dec 30)
|
| Fri, Dec 18, 2009 |
| |
3 Reasons to Buy Dendreon Today at Motley Fool (Fri, Dec 18)
|
| |
CelgeneÂs Surprising New Hope for Blood Cancer at Minyanville.com (Fri, Dec 18)
|
| Fri, Dec 11, 2009 |
| |
Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies PRNewswire (Fri, Dec 11)
|
| Older Headlines |
|
|
|
|